Patient Activation Measure

The Patient Activation Measure (PAM) is a commercial product which assesses an individual’s knowledge, skill, and confidence for managing one’s health and healthcare. Individuals who measure high on this assessment typically understand the importance of taking a pro-active role in managing their health and have the skills and confidence to do so.

The PAM survey measures patients on a 0-100 scale and can segment patients into one of four activation levels along an empirically derived continuum. Each activation level reveals insight into an array of health-related characteristics, including attitudes, motivators, behaviors, and outcomes.

Development and science
PAM was developed using qualitative methods, Rasch analysis, and classical test theory psychometric methods. Developed by Judith Hibbard and colleagues at the University of Oregon, the resulting 13-item measure is a uni-dimensional, interval level, Guttman-like scale. The PAM has strong psychometric properties, and has been translated into 19 different languages. The measure is currently used to assess patient activation or engagement by researchers and clinicians around the world. PAM is offered to healthcare organizations exclusively by Insignia Health, a company based in Portland, Oregon.

Research
Multiple studies show that PAM scores are predictive of most health behaviors, including preventive behaviors (e.g. obtaining screenings and immunizations); healthy behaviors (e.g. healthy diet and regular exercise); self-management behaviors (e.g. monitoring and medication management); and health information seeking. Higher activated individuals also have better health outcomes and lower rates of costly utilization, such as emergency department use and hospitalizations.

Further there is evidence that with support and appropriate interventions it is possible to increase activation levels in patients.

The Patient Activation Measure is being used in a number of ways to improve the delivery of health care, including:
 * a metric to assess the degree to which patient's are prepared and able to self-manage
 * to tailor support and education to help them increase in activation
 * to track the impact of interventions and tailored support on increasing patient activation levels
 * to segment an enrolled patient population, and direct more resources to the low activated patients (a more efficient use of resources ).

Use through Insignia Health
Insignia Health holds the worldwide exclusive rights to PAM per a technology transfer from University of Oregon. Insignia licenses PAM and other related products to organizations in the U.S. and abroad. PAM is being used in 16 countries today.